1711 - In Vitro Activity of Cefiderocol Against US Achromobacter spp. and Burkholderia spp. Clinical Isolates from the SENTRY Surveillance Program 2020-2021

Director, Head of Infectious Diseases 5, Laboratory for Drug Discovery and Disease Research
Shionogi & Co., Ltd
Toyonaka, Osaka, Japan

Senior Director Microbiology
JMI Laboratories
North Liberty, Iowa, United States

Shionogi Inc.
Florham Park, New Jersey, United States

Senior Director, Scientific Affairs EU
Shionogi B.V.
London, England, United Kingdom

Consultant
Infectious Disease Drug Development Consulting
Easton, Connecticut, United States

Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan